Topoisomerase IIβ Kinase: A protein processed from HIV-1 envelope by cysteine proteases
Topoisomerase IIβ (TopoIIβ) is activated by TopoIIβ kinase (TopoIIβK) during HIV-1 infection. This study demonstrates that TopoIIβK is produced within 15-30 minutes post-infection and is conserved across the major HIV-1 subtypes (A, B, C, and D), although its formation kinetics vary among subtypes. Immunological mapping using specific anti-gp120 antibodies suggests that TopoIIβK is derived from the N-terminal region of gp120. Notably, TopoIIβK co-localizes with endolysosomes shortly after viral entry. Inhibition of cysteine proteases using E64d and Z-FY-CHO abrogates TopoIIβK production in both HIV-1-infected and envelope-transfected cells. These findings suggest that TopoIIβK is a conserved polypeptide product of gp120 processing within endolysosomes during the early stages of HIV-1 infection, highlighting a potentially conserved mechanism that regulates early viral infection across major HIV-1 subtypes.
Authors
- Satyajit Mukhopadhyay
- Anand Kumar Kondapi (ORCID: https://orcid.org/0000-0002-0711-3126)
- Sangeetha Balasubramanian (ORCID: https://orcid.org/0000-0002-4525-6152)
- Ritika Das (ORCID: https://orcid.org/0000-0002-4197-7382)
- Hema Verma
- Abhash Kumar
- Balakrishna S Lokeswara
Institutions
- University of Hyderabad (IN)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-10-28
- DOI
- https://doi.org/10.64898/2026.10.26.761857
- Primary Topic
- HIV Research and Treatment
- Type
- preprint
Funders
- Department of Biotechnology, Ministry of Science and Technology, India
- Department of Science and Technology, Ministry of Science and Technology, India
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases